"Up to 80% of oncological patients receive anesthesia and/or analgesia for diagnostic, therapeutic or palliative interventions. Therefore, anesthesiologists are asked to administer drugs such as opiates and volatile or intravenous anesthetics, which may determine different effects on immunomodulation and cancer recurrence. For instance, some studies suggest that intravenous drugs, such as propofol, may inhibit the host immunity to a lower extent as compared to volatile anesthetics. " - F. Longini et al. Cancer Manag Res. 2020; 12: 931–940.
Anesthetic opiates may interact with ... - Fight Prostate Ca...
Anesthetic opiates may interact with the immune system in negative ways.
Written by
kainasar
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Pinostilbene inhibits the Enz-resistant CRPC cell line by inhibiting AR variant 7
i take pterostilbene daily which pinostilbene is a metabolite of pterostilbene.
in any event if...
Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy
New paper from Spain [1].
"... we will review those strategies and drugs that are able to...
Glutamine blockade to starve tumors, Using bacteria in the microbiome to attack cancer, 2 articles on finding dormant cancer cells in bone
Greetings FPC Members,
First, a glutamine uptake blocker, IMD-0354, in development to starve...
New cancer treatment immuno therapy combined with guadecitabine in lung, breast, prostate bowel cancer makes cancer visible to immune sys
A new cancer treatment can stop the disease advancing in patients who are resistant to...
Gut Microbiome Varies Hour to Hour, Month to Month - Intraindividual shifts over time may explain why drugs don't work the same in everyone
Gut Microbiome Varies Hour to Hour, Month to Month - Intraindividual shifts over time may...
Related Posts
Understanding the Abscopal Effect and its Potential Role in Developing a Cure for Cancer-Part 2-Possible Ways to Ensure the Abscopal Effect- Scientists develop "tumor on a chip" for testing cancer drugs, AND CRISPR-Cas 9 screens lead to largest dataset of targets in cancers
Prostate cancer - repurposed drugs?- Cancer and Atherosclerosis targeting, A New Blood test to guide treatment, Targeting drug resistance in PCa
Efficacy and safety of BAT in CRPC following Abi or Enza resistance: A systematic review
